TY - JOUR
T1 - Equivariant 3D-Conditional Diffusion Model for de Novo Drug Design
AU - Zheng, Jia
AU - Yi, Hai Cheng
AU - You, Zhu Hong
N1 - Publisher Copyright:
© 2013 IEEE.
PY - 2025
Y1 - 2025
N2 - De novo drug design speeds up drug discovery, mitigating its time and cost burdens with advanced computational methods. Previous work either insufficiently utilized the 3D geometric structure of the target proteins, or generated ligands in an order that was inconsistent with real physics. Here we propose an equivariant 3D-conditional diffusion model, named DiffFBDD, for generating new pharmaceutical compounds based on 3D geometric information of specific target protein pockets. DiffFBDD overcomes the underutilization of geometric information by integrating full atomic information of pockets to backbone atoms using an equivariant graph neural network. Moreover, we develop a diffusion approach to generate drugs by generating ligand fragments for specific protein pockets, which requires fewer computational resources and less generation time (65.98% ∼ 96.10% lower). DiffFBDD offers better performance than state-of-the-art models in generating ligands with strong binding affinity to specific protein pockets, while maintaining high validity, uniqueness, and novelty, with clear potential for exploring the drug-like chemical space.
AB - De novo drug design speeds up drug discovery, mitigating its time and cost burdens with advanced computational methods. Previous work either insufficiently utilized the 3D geometric structure of the target proteins, or generated ligands in an order that was inconsistent with real physics. Here we propose an equivariant 3D-conditional diffusion model, named DiffFBDD, for generating new pharmaceutical compounds based on 3D geometric information of specific target protein pockets. DiffFBDD overcomes the underutilization of geometric information by integrating full atomic information of pockets to backbone atoms using an equivariant graph neural network. Moreover, we develop a diffusion approach to generate drugs by generating ligand fragments for specific protein pockets, which requires fewer computational resources and less generation time (65.98% ∼ 96.10% lower). DiffFBDD offers better performance than state-of-the-art models in generating ligands with strong binding affinity to specific protein pockets, while maintaining high validity, uniqueness, and novelty, with clear potential for exploring the drug-like chemical space.
KW - Drug discovery
KW - artificial intelligence
KW - equivariant diffusion model
KW - fragment-based drug design
KW - molecular generation
UR - http://www.scopus.com/inward/record.url?scp=85209098282&partnerID=8YFLogxK
U2 - 10.1109/JBHI.2024.3491318
DO - 10.1109/JBHI.2024.3491318
M3 - 文章
C2 - 39495691
AN - SCOPUS:85209098282
SN - 2168-2194
VL - 29
SP - 1805
EP - 1816
JO - IEEE Journal of Biomedical and Health Informatics
JF - IEEE Journal of Biomedical and Health Informatics
IS - 3
ER -